NCT05919082 - A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis | Biotech Hunter

Enrollment

604

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

March 5, 2024

Conditions

Stable Plaque Psoriasis

Interventions

DRUG

LEO 90100

Subjects will apply LEO 90100 topically; up to 15 g per day (or 105 g per week).

DRUG

Daivobet® ointment

Subjects will apply Daivobet® ointment topically; up to 15 g per day (or 105 g per week).

Trial Locations (38)

100044

LEO Pharma Investigational Site, Beijing

100050

LEO Pharma Investigational Site, Beijing

130021

LEO Pharma Investigational Site, Changchun

200443

LEO Pharma Investigational Site, Shanghai

212001

LEO Pharma Investigational Site, Zhenjiang

214002

LEO Pharma Investigational Site, Wuxi

225003

LEO Pharma Investigational Site, Yangzhou

230022

LEO Pharma Investigational Site, Hefei

233060

LEO Pharma Investigational Site, Bengbu

250013

LEO Pharma Investigational Site, Jinan

250022

LEO Pharma Investigational Site, Jinan

257099

LEO Pharma Investigational Site, Dongying

310003

LEO Pharma Investigational Site, Hangzhou

310009

LEO Pharma Investigational Site, Hangzhou

310014

LEO Pharma Investigational Site, Hangzhou

310016

LEO Pharma Investigational Site, Hangzhou

314001

LEO Pharma Investigational Site, Jiaxing

315010

LEO Pharma Investigational Site, Ningbo

315016

LEO Pharma Investigational Site, Ningbo

325000

LEO Pharma Investigational Site, Wenzhou

400021

LEO Pharma Investigational Site, Chongqing

400042

LEO Pharma Investigational Site, Chongqing

410011

LEO Pharma Investigational Site, Changsha

430022

LEO Pharma Investigational Site, Wuhan

442000

LEO Pharma Investigational Site, Shiyan

473004

LEO Pharma Investigational Site, Nanyang

510080

LEO Pharma Investigational Site, Guangzhou

LEO Pharma Investigational Site, Xi'an

516006

LEO Pharma Investigational Site, Guangzhou

518020

LEO Pharma Investigational Site, Shenzhen

610044

LEO Pharma Investigational Site, Chengdu

629000

LEO Pharma Investigational Site, Suining

061000

LEO Pharma Investigational Site, Cangzhou

067000

LEO Pharma Investigational Site, Chengde

050030

LEO Pharma Investigational Site, Shijiangzhuang

014010

LEO Pharma Investigational Site, Baotou

014016

LEO Pharma Investigational Site, Baotou

010000

LEO Pharma Investigational Site, Hohhot